Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
$ABMD
$ACOR
$AGLE
$AMBO
Medical/Dental Instruments
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Gainers
- Safe-T Group Ltd (NASDAQ:SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
- Abiomed, Inc. (NASDAQ:ABMD) shares jumped 50.4% to $379.01 after Johnson & Johnson announced it will acquire the company. Also, the company reported better-than-expected Q2 adjusted EPS results.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) surged 35.7% to $2.62. Sonnet BioTherapeutics recently announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
- IDEX Biometrics ASA (NASDAQ:IDBA) gained 28.8% to $7.61.
- Aravive, Inc. (NASDAQ:ARAV) climbed 26.3% to $1.65.
- ReTo Eco-Solutions, Inc. (NASDAQ:RETO) gained 23.7% to $0.6801.
- Ambow Education Holding Ltd. (NYSE:AMBO) climbed 18.9% to $0.3094.
- MINISO Group Holding Limited (NYSE:MNSO) gained 17.3% to $5.98.
- Atai Life Sciences N.V. (NASDAQ:ATAI) surged 17% to $3.47 after Loop Capital initiated coverage on the stock with a Buy rating and a $18 price target.
- Harsco Corporation (NYSE:HSC) rose 16.6% to $6.17 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance.
- Uber Technologies, Inc. (NYSE:UBER) gained 16% to $30.82 after the company reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.
- Cyxtera Technologies, Inc. (NASDAQ:CYXT) jumped 15.5% to $2.7950.
- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) surged 15.4% to $1.1803. Wells Fargo recently upgraded the stock from Equal-Weight to Overweight and raised its price target from $1.5 to $2.
- Carvana Co. (NYSE:CVNA) rose 15.2% to $15.58 after JP Morgan upgraded the stock from Underweight to Neutral and announced a $20 price target.
- SoFi Technologies, Inc. (NASDAQ:SOFI) gained 15% to $6.26 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance.
- Zai Lab Limited (NASDAQ:ZLAB) shares gained 13.8% to $25.38. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- Blucora, Inc. (NASDAQ:BCOR) rose 13.2% to $24.95 after the company reported better-than-expected Q3 sales results and announced it sold TaxAct for $720 million in cash.
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) gained 12.8% to $12.89 after the company posted a profit for the third quarter.
- RLX Technology Inc. (NYSE:RLX) rose 12% to $1.40 after declining over 7% on Monday.
- GDS Holdings Limited (NASDAQ:GDS) shares rose 11.8% to $9.65 after dipping more than 10% on Monday.
- Kanzhun Limited (NASDAQ:BZ) climbed 10% to $12.02. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- H World Group Limited (NASDAQ:HTHT) shares rose 9.8% to $29.74.
- Trip.com Group Limited (NASDAQ:TCOM) shares rose 9.8% to $24.85 amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- iQIYI, Inc. (NASDAQ:IQ) rose 9.7% to $2.2150. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- IDEXX Laboratories, Inc. (NASDAQ:IDXX) gained 8.7% to $390.89 after the company reported better-than-expected Q3 EPS and sales results.
- Lattice Semiconductor Corporation (NASDAQ:LSCC) climbed 8.5% to $52.63 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance above analyst estimates.
- Lyft, Inc. (NASDAQ:LYFT) gained 8.5% to $15.90 in sympathy with Uber, which reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.
- Hologic, Inc. (NASDAQ:HOLX) rose 8.4% to $73.47 after the company reported better-than-expected Q3 EPS and sales results.
Losers
- Varonis Systems, Inc. (NASDAQ:VRNS) shares dipped 32.5% to $18.08 after the company reported worse-than-expected Q3 results.
- Catalent, Inc. (NYSE:CTLT) fell 26.5% to $48.34 after the company reported worse-than-expected Q1 EPS and sales results and issued FY23 sales guidance below estimates.
- Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) dropped 22.1% to $5.07. Coeptis Therapeutics announced closing of business combination with Bull Horn Holdings Corp.
- Myriad Genetics, Inc. (NASDAQ:MYGN) fell 19.1% to $16.78 following downbeat Q3 results.
- Satixfy Communications Ltd. (NYSE:SATX) dipped 19% to $13.20.
- LMF Acquisition Opportunities, Inc. (NASDAQ:ICU) fell 18.8% to $8.84.
- Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) fell 18.3% to $2.32.
- Instil Bio, Inc. (NASDAQ:TIL) fell 18.3% to $2.6900. Instil Bio voluntarily paused enrollment of its ongoing clinical trials. Cowen & Co. downgraded Instil Bio from Outperform to Market Perform.
- Ever-Glory International Group, Inc. (NASDAQ:EVK) dropped 17.3% to $0.8101.
- TETRA Technologies, Inc. (NYSE:TTI) declined 17.2% to $4.09 following weak quarterly results.
- Solaris Oilfield Infrastructure, Inc. (NYSE:SOI) dropped 17.2% to $11.23 following downbeat quarterly sales.
- Argo Blockchain plc (NASDAQ:ARBK) fell 16.2% to $0.93. Argo Blockchain shares dipped around 44% on Monday after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be conssumated.
- Selina Hospitality PLC (NASDAQ:SLNA) fell 16.2% to $10.80.
- Transcat, Inc. (NASDAQ:TRNS) dropped 15.8% to $69.64 following Q2 results.
- The Goodyear Tire & Rubber Company (NASDAQ:GT) fell 15.4% to $10.75 after the company reported worse-than-expected Q3 earnings.
- Zebra Technologies Corporation (NASDAQ:ZBRA) dropped 15.4% to $239.65 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS guidance below analyst estimates.
- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) fell 14.6% to $11.40 after the company reported Q3 earnings results and issued FY22 guidance.
- Clearwater Paper Corporation (NYSE:CLW) declined 12.8% to $38.75 following Q3 results. RBC Capital downgraded Clearwater Paper from Outperform to Sector Perform.
- OrthoPediatrics Corp. (NASDAQ:KIDS) fell 12.1% to $37.35 after the company issued FY22 revenue guidance below estimates.
- Stryve Foods, Inc. (NASDAQ:SNAX) dropped 11.7% to $0.2471.
- Avis Budget Group, Inc. (NASDAQ:CAR) fell 9.9% to $213.03 following Q3 results.
- TopBuild Corp. (NYSE:BLD) dropped 9.7% to $153.66 following Q3 results.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares fell 9.5% to $0.9679 after jumping over 63% on Monday.
- Evolent Health, Inc. (NYSE:EVH) declined 9.4% to $28.82. Truist Securities initiated coverage on Evolent Health with a Hold rating and announced a price target of $33.
- Harmonic Inc. (NASDAQ:HLIT) dropped 9.3% to $14.01 following Q3 results.
- Sealed Air Corporation (NYSE:SEE) dipped 9.2% to $43.26 after the company announced it will acquire Liquibox for $1.15 billion. The company also reported worse-than-expected Q3 sales.
- Ecolab Inc. (NYSE:ECL) dropped 8.8% to $143.25 after the company reported worse-than-expected Q3 EPS results.
- SeqLL Inc. (NASDAQ:SQL) fell 8.1% to $0.5412.
- Babcock & Wilcox Enterprises, Inc. (NYSE:BW) declined 8.1% to $4.19.
- Canopy Growth Corporation (NASDAQ:CGC) dropped 8% to $3.43.
- Kforce Inc. (NASDAQ:KFRC) fell 7.8% to $58.33 after reporting Q3 results.
- Stryker Corporation (NYSE:SYK) fell 4.3% to $219.50 after the company reported worse-than-expected Q3 results and issued 2022 guidance below estimates.